ASweetLife Team

Cashew Seed Extract Shown To Stimulate Blood Sugar Absorption

According to a new study from the University of Montreal (Canada) and the Université de Yaoundé (Cameroun) cashew seed extract shows promise as an effective anti-diabetic, EurekAlet reports. Published in the journal Molecular Nutrition & Food Research, the investigation analyzed the reputed health...
0 Shares
gsk-logo

Diabetes Drug Maker Hid Study Data

Avandia Safety Questioned: The New York Times reports that diabetes drug maker SmithKline did not reveal the results of a study showing its drug Avandia was riskier to the heart than a competing drug, Actos. The New York Times states, "instead of publishing the results, the company spent the next 11 years trying to cover them up, according to documents recently obtained by The New York Times. The company did not ...
0 Shares
biodel_logo

Biodel Reports Progress in Development of Glucose-Regulated ‘Smart’ Basal Insulin

Biodel Inc. reported results of preclinical tests which demonstrated the potential of the company's glucose-regulated or "smart" basal insulin product candidate, BIOD620, to release insulin proportionally in response to changing glucose conditions. In an oral presentation today at the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland...
0 Shares
U of Florida Logo

Type 1 Diabetes Linked to Children’s Gut Bacteria

University of Florida researchers have found that the variety of bacteria in a child’s digestive tract is strongly linked to whether that child develops type 1 diabetes. The connection could eventually give doctors an early test for the condition and a new way to treat the disease that afflicts more than 3 million Americans...
0 Shares
biodel logo

JDRF Grants $407,000 to Evaluate Use of Biodel’s VIAject(R) in Treatment of Diabetes

Biodel Inc. announced the award of two research grants by the Juvenile Diabetes Research Foundation (JDRF) to Stanford University and Oregon Health & Science University (OHSU) to evaluate the use of VIAject(R) (ultra-rapid-acting injectable human insulin) in the treatment of diabetes. The first grant will support clinical testing under the direction...
0 Shares
Egg

High Protein Snacks

Until my diabetes diagnosis, I was a big snacker - a few pretzels here, an apple there... Now I find snacking to be a complicated issue, not something that is fun and mindless. Since I'm on the go all day with my three sons, I don't have time to prepare anything in between meals, and sometimes I need more than just coffee!
0 Shares
gsk-logo

Avandia Recall Possible: FDA Reviews

The diabetes drug, Avandia, may be more dangerous than was previously reported. According to CNN, a review of Avandia released last week by the FDA states that officials overseeing GlaxoSmithKline Plc’s RECORD study repeatedly submitted sloppy data and failed to follow up on reports of problems in patients -- including reports of patient deaths...
0 Shares
Diamedica logo

DiaMedica Initiates New Type 1 Diabetes Program

DiaMedica Inc., a Canadian biopharmaceutical company focused on developing novel treatments for diabetes and neurological disorders, announced the initiation of a type 1 diabetes program following the acquisition of Sanomune. The initiation of this program is based on encouraging preclinical results with DM-99, a naturally occurring protein that the company has previously...
0 Shares

Type 2 Diabetes in Vietnam

A study by Australian and Vietnamese scientists found about 11% of men and 12% of women in Vietnam's Ho Chi Minh City had undiagnosed type 2 diabetes, according to a BBC report. This was in addition to the 4% of people who had been diagnosed...
0 Shares
JDRF New Logo

JDRF and Sanofi-aventis Join Forces in Search of Cure for Type 1 Diabetes

Sanofi-aventis and the Juvenile Diabetes Research Foundation (JDRF) announced a unique partnership to develop therapeutic treatments for people with type 1 diabetes at different stages of the disease - both those living with the disease and the newly diagnosed - as well as preventing diabetes in those at risk...
0 Shares